BCM
SNY icon

Baltimore Capital Management’s Sanofi SNY Stock Holding History

Baltimore Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-31,100
Closed -$1.41M – 75
2017
Q1 		$1.41M Buy
+31,100
New +$1.32M 1.87% 18

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baltimore Capital Management's SNY Position: Q2 2017 in Review

Baltimore Capital Management sold out of Sanofi (SNY) in Q2 2017, closing a stake of 31,100 shares — an estimated $1.41M sold.

Baltimore Capital Management first reported a position in SNY in Q1 2017 and held it in 1 quarter. The position peaked at $1.41M in Q1 2017. 474 funds tracked by Wall St. Rank hold SNY as of Q2 2017.

  • Baltimore Capital Management reported no remaining Sanofi position as of Q2 2017 after selling out during the quarter.
  • Baltimore Capital Management sold 31,100 Sanofi shares in Q2 2017, an estimated $1.41M.
  • Baltimore Capital Management first reported a position in Sanofi in Q1 2017 and held it in 1 quarter.
  • Baltimore Capital Management's Sanofi position peaked at $1.41M in Q1 2017.
  • 474 funds tracked by Wall St. Rank held Sanofi as of Q2 2017.

Based on Baltimore Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.